Bortezomib

Overview

Bortezomib is a potent, reversible and selective 20S proteasome inhibitor with a Ki of 0.6 nM. It is an antineoplastic agent that is used in treatment of refractory multiple myeloma and certain lymphomas.

Application

Products > Drug Discovery > Impurities > Anti-Neoplastic > Bortezomib and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-293315
• CAS No.: 179324-69-7
• Molecular Formula: C19H25BN4O4
• Molecular Weight: 384.24
• Purity: >98%
• Storage: Store at -20°C
• Solubility: Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)

Source

Original product source